2022
DOI: 10.1016/j.mri.2022.08.006
|View full text |Cite
|
Sign up to set email alerts
|

Parallel transmission 2D RARE imaging at 7T with transmit field inhomogeneity mitigation and local SAR control

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 70 publications
(100 reference statements)
0
6
0
Order By: Relevance
“…For this strategy, a set of numerical pregnant body models is needed to determine the scaling factor necessary to decrease the wbSAR limit . Although very practical, this strategy is indirect, conservative, and can be detrimental to pTx performance 10,17–19 Strategy B: Explicitly constrain maternal and fetal pSAR10g and fetal aveSAR by using subject‐specific numerical body models while keeping wbSAR limit at the regulatory limit.…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations
“…For this strategy, a set of numerical pregnant body models is needed to determine the scaling factor necessary to decrease the wbSAR limit . Although very practical, this strategy is indirect, conservative, and can be detrimental to pTx performance 10,17–19 Strategy B: Explicitly constrain maternal and fetal pSAR10g and fetal aveSAR by using subject‐specific numerical body models while keeping wbSAR limit at the regulatory limit.…”
Section: Methodsmentioning
confidence: 99%
“…Although very practical, this strategy is indirect, conservative, and can be detrimental to pTx performance. 10,[17][18][19] • Strategy B: Explicitly constrain maternal and fetal pSAR10g and fetal aveSAR by using subject-specific numerical body models while keeping wbSAR limit at the regulatory limit. For this strategy, each subject's numerical body model is needed to estimate their SAR values.…”
Section: Local Sar Management Strategiesmentioning
confidence: 99%
See 2 more Smart Citations
“…Many researchers have conducted comparative studies on the injection dose at 1.5T versus 3.0 T, and 3.0 T versus 7.0T, and showed the feasibility for injecting less-dose contrast agents at higher field MRI for brain tumours [11,12]. However, whole body imaging at 7.0 T has not been approved by the FDA and is not available in the clinic, due to safety issues such as increased specific absorption rate (SAR) distributions at the body and technical issues such as B1 field inhomogeneity [13,14]. Recently, a 5.0 T clinical MRI scanner was invented, and can be used to scan the whole body with good image homogeneity and contrast uniformity, meanwhile avoid issues such as high SAR [15].…”
Section: Introductionmentioning
confidence: 99%